Education
About Us
Working with TipRanks
Follow Us
Azenta (AZTA)
NASDAQ:AZTA
AZTA Stock Chart & Stats
$29.75
-$0.47(-0.91%)
At close: 4:00 PM EST
$29.75
-$0.47(-0.91%)
Day’s Range― - ―
52-Week Range$23.91 - $55.64
Previous CloseN/A
Volume88.55K
Average Volume (3M)587.59K
Market Cap
$1.38B
Enterprise Value$1.14B
Total Cash (Recent Filing)$318.86M
Total Debt (Recent Filing)$52.63M
Price to Earnings (P/E)―
Beta1.07
Next Earnings
Nov 18, 2025EPS Estimate
0.19Last Dividend Ex-Date
Dec 02, 2021Dividend YieldN/A
Share Statistics
EPS (TTM)0.19
Shares Outstanding45,839,730
10 Day Avg. Volume463,449
30 Day Avg. Volume587,594
Financial Highlights & Ratios
PEG Ratio-0.01
Price to Book (P/B)1.46
Price to Sales (P/S)3.92
P/FCF Ratio199.72
Enterprise Value/Market Cap0.82
Enterprise Value/Revenue1.89
Enterprise Value/Gross Profit4.20
Enterprise Value/Ebitda31.54
Forecast
1Y Price Target
$35.25Price Target Upside18.49% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering4
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Bulls Say, Bears Say
Bulls Say
Financial GuidanceManagement reaffirmed FY25 guidance of +3-5% y/y growth in topline revs, which assumes MSD growth in Multiomics & LSD growth in SMS.
Growth OpportunitiesThere is a lot of opportunity ahead with growth drivers such as innovation, pricing, attach rates, and M&A upside.
Management StrategyThe new management team has built an improved foundation for an attractive mid-term story with accelerating growth and plenty of margin runway.
Bears Say
Revenue MissFQ3 total revs of $144M missed consensus $149M largely due to geo-driven slowdown in both storage and gene synthesis segments.
Sector ChallengesThe academic and government sector, which is about 20% of the mix, is likely to remain an overhang.
Azenta News
AZTA FAQ
What was Azenta’s price range in the past 12 months?
Azenta lowest stock price was $23.91 and its highest was $55.63 in the past 12 months.
What is Azenta’s market cap?
Azenta’s market cap is $1.38B.
When is Azenta’s upcoming earnings report date?
Azenta’s upcoming earnings report date is Nov 18, 2025 which is in 2 days.
How were Azenta’s earnings last quarter?
Azenta released its earnings results on Aug 05, 2025. The company reported $0.19 earnings per share for the quarter, beating the consensus estimate of $0.136 by $0.054.
Is Azenta overvalued?
According to Wall Street analysts Azenta’s price is currently Undervalued.
Does Azenta pay dividends?
Azenta pays a Quarterly dividend of $0.1 which represents an annual dividend yield of N/A. See more information on Azenta dividends here
What is Azenta’s EPS estimate?
Azenta’s EPS estimate is 0.19.
How many shares outstanding does Azenta have?
Azenta has 45,839,730 shares outstanding.
What happened to Azenta’s price movement after its last earnings report?
Azenta reported an EPS of $0.19 in its last earnings report, beating expectations of $0.136. Following the earnings report the stock price went down -17.001%.
Which hedge fund is a major shareholder of Azenta?
Currently, no hedge funds are holding shares in AZTA
Azenta Stock Smart Score
Underperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$35.25 (18.49% Upside)
$35.25 (18.49% Upside)
Hedge Fund Trend
Decreased
By 379.5K Shares
Last Quarter.
Last Quarter.
Insider Transactions
Sold Shares
Worth $9.3K over
the Last 3 Months
the Last 3 Months
Crowd Wisdom
Very Negative
Last 7 Days ▼ 1.1%
Last 30 Days ▼ 5.3%
Last 30 Days ▼ 5.3%
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-28.47%
12-Months-Change
Fundamentals
Return on Equity
-1.74%
Trailing 12-Months
Asset Growth
-13.09%
Trailing 12-Months
Company Description
Azenta
Azenta, Inc. (AZTA) is a leading provider of life sciences solutions, focusing on biobanking and laboratory services. The company operates primarily in the biotechnology and pharmaceutical sectors, offering a range of products and services such as sample management, genomic analysis, and data solutions. Azenta's mission is to empower researchers and organizations in the life sciences field by providing innovative solutions that enhance the efficiency and effectiveness of their research processes.
AZTA Company Deck
AZTA Earnings Call
Q3 2025
0:00 / 0:00
Earnings Call Sentiment|Neutral
While Azenta demonstrated strong financial management, margin expansion, and specific growth areas like next-gen sequencing, the company also faced challenges with core product revenue declines and specific segment weaknesses. The reaffirmation of guidance indicates confidence despite these headwinds.View all AZTA earnings summariesAZTA Stock 12 Month Forecast
Average Price Target
$35.25
▲(18.49% Upside)
Technical Analysis
Ownership Overview
11.43% Insiders
31.54% Mutual Funds
0.17% Other Institutional Investors
27.90% Public Companies and
Individual Investors